Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma

Clinical trial NCT07460245 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07460245
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma

Start date: 2026-06-01
Primary completion: 2026-06-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.